Early Detection of Nerve Fiber Loss by Corneal Confocal Microscopy and Skin Biopsy in Recently Diagnosed Type 2 Diabetes

  • Dan Ziegler
    Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research, Düsseldorf, Germany
  • Nikolaos Papanas
    Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research, Düsseldorf, Germany
  • Andrey Zhivov
    Department of Ophthalmology, University of Rostock, Rostock, Germany
  • Stephan Allgeier
    Institute for Applied Computer Science and Automation, Karlsruhe Institute of Technology, Karlsruhe, Germany
  • Karsten Winter
    Translational Centre for Regenerative Medicine, University of Leipzig, Leipzig, Germany.
  • Iris Ziegler
    Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research, Düsseldorf, Germany
  • Jutta Brüggemann
    Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research, Düsseldorf, Germany
  • Alexander Strom
    Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research, Düsseldorf, Germany
  • Sabine Peschel
    Department of Ophthalmology, University of Rostock, Rostock, Germany
  • Bernd Köhler
    Institute for Applied Computer Science, Karlsruhe Institute of Technology, Karlsruhe, Germany
  • Oliver Stachs
    Department of Ophthalmology, University of Rostock, Rostock, Germany
  • Rudolf F. Guthoff
    Department of Ophthalmology, University of Rostock, Rostock, Germany
  • Michael Roden
    Institute for Clinical Diabetology, German Diabetes Center at Heinrich Heine University, Leibniz Center for Diabetes Research, Düsseldorf, Germany

説明

<jats:p>We sought to determine whether early nerve damage may be detected by corneal confocal microscopy (CCM), skin biopsy, and neurophysiological tests in 86 recently diagnosed type 2 diabetic patients compared with 48 control subjects. CCM analysis using novel algorithms to reconstruct nerve fiber images was performed for all fibers and major nerve fibers (MNF) only. Intraepidermal nerve fiber density (IENFD) was assessed in skin specimens. Neurophysiological measures included nerve conduction studies (NCS), quantitative sensory testing (QST), and cardiovascular autonomic function tests (AFTs). Compared with control subjects, diabetic patients exhibited significantly reduced corneal nerve fiber length (CNFL-MNF), fiber density (CNFD-MNF), branch density (CNBD-MNF), connecting points (CNCP), IENFD, NCS, QST, and AFTs. CNFD-MNF and IENFD were reduced below the 2.5th percentile in 21% and 14% of the diabetic patients, respectively. However, the vast majority of patients with abnormal CNFD showed concomitantly normal IENFD and vice versa. In conclusion, CCM and skin biopsy both detect nerve fiber loss in recently diagnosed type 2 diabetes, but largely in different patients, suggesting a patchy manifestation pattern of small fiber neuropathy. Concomitant NCS impairment points to an early parallel involvement of small and large fibers, but the precise temporal sequence should be clarified in prospective studies.</jats:p>

収録刊行物

  • Diabetes

    Diabetes 63 (7), 2454-2463, 2014-06-14

    American Diabetes Association

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ